Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.
Saved in:
| Title: | Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial. |
|---|---|
| Authors: | Wang, De-Shen1 (AUTHOR), Ren, Chao1 (AUTHOR), Li, Shan-Shan2 (AUTHOR), Fong, William Pat1 (AUTHOR), Wu, Xiao-Jun3 (AUTHOR), Xiao, Jian2,4 (AUTHOR), Li, Bin-Kui5 (AUTHOR), Zheng, Yun5 (AUTHOR), Ding, Pei-Rong3 (AUTHOR), Chen, Gong3 (AUTHOR), Qiu, Miao-Zhen1 (AUTHOR), Wang, Zhi-Qiang1 (AUTHOR), Wang, Feng-Hua1 (AUTHOR), Luo, Hui-Yan1 (AUTHOR), Wang, Feng1 (AUTHOR), Wang, Xiao-Zhong6 (AUTHOR), Wang, Ling-Yun7 (AUTHOR), Xie, De-Jin6 (AUTHOR), Chen, Tao7 (AUTHOR), Li, Li-Ren3 (AUTHOR) |
| Source: | PLoS Medicine. 5/10/2024, Vol. 21 Issue 5, p1-18. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 177203689 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Wang%2C+De-Shen%22">Wang, De-Shen</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ren%2C+Chao%22">Ren, Chao</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Shan-Shan%22">Li, Shan-Shan</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fong%2C+William+Pat%22">Fong, William Pat</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Xiao-Jun%22">Wu, Xiao-Jun</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xiao%2C+Jian%22">Xiao, Jian</searchLink><relatesTo>2,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Bin-Kui%22">Li, Bin-Kui</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zheng%2C+Yun%22">Zheng, Yun</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ding%2C+Pei-Rong%22">Ding, Pei-Rong</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Gong%22">Chen, Gong</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qiu%2C+Miao-Zhen%22">Qiu, Miao-Zhen</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Zhi-Qiang%22">Wang, Zhi-Qiang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Feng-Hua%22">Wang, Feng-Hua</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Luo%2C+Hui-Yan%22">Luo, Hui-Yan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Feng%22">Wang, Feng</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Xiao-Zhong%22">Wang, Xiao-Zhong</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Ling-Yun%22">Wang, Ling-Yun</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xie%2C+De-Jin%22">Xie, De-Jin</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Tao%22">Chen, Tao</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Li-Ren%22">Li, Li-Ren</searchLink><relatesTo>3</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22PLoS+Medicine%22">PLoS Medicine</searchLink>. 5/10/2024, Vol. 21 Issue 5, p1-18. 18p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=177203689 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pmed.1004389 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 18 StartPage: 1 Titles: – TitleFull: Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wang, De-Shen – PersonEntity: Name: NameFull: Ren, Chao – PersonEntity: Name: NameFull: Li, Shan-Shan – PersonEntity: Name: NameFull: Fong, William Pat – PersonEntity: Name: NameFull: Wu, Xiao-Jun – PersonEntity: Name: NameFull: Xiao, Jian – PersonEntity: Name: NameFull: Li, Bin-Kui – PersonEntity: Name: NameFull: Zheng, Yun – PersonEntity: Name: NameFull: Ding, Pei-Rong – PersonEntity: Name: NameFull: Chen, Gong – PersonEntity: Name: NameFull: Qiu, Miao-Zhen – PersonEntity: Name: NameFull: Wang, Zhi-Qiang – PersonEntity: Name: NameFull: Wang, Feng-Hua – PersonEntity: Name: NameFull: Luo, Hui-Yan – PersonEntity: Name: NameFull: Wang, Feng – PersonEntity: Name: NameFull: Wang, Xiao-Zhong – PersonEntity: Name: NameFull: Wang, Ling-Yun – PersonEntity: Name: NameFull: Xie, De-Jin – PersonEntity: Name: NameFull: Chen, Tao – PersonEntity: Name: NameFull: Li, Li-Ren IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 05 Text: 5/10/2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 15491277 Numbering: – Type: volume Value: 21 – Type: issue Value: 5 Titles: – TitleFull: PLoS Medicine Type: main |
| ResultId | 1 |